[{"Assets_0_Q3_USD":980415000.0,"CommonStockSharesOutstanding_0_Q3_shares":137144902.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-86878000.0,"NetIncomeLoss_1_Q3_USD":-57324000.0,"NetIncomeLoss_3_Q3_USD":-168871000.0,"StockholdersEquity_0_Q3_USD":539399000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":32448000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":117389000.0,"Ticker":"PGEN","CIK":"1356090","name":"INTREXON CORP","OfficialName":"Precigen Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337298902.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]